Skip to content
healthcare.dev

levocetirizine dihydrochloride

NDC 50228-136, levocetirizine dihydrochloride, tablet, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-136
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203646
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-136 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOCETIRIZINE DIHYDROCHLORIDE5 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
50228-136-10502280136101000 TABLET in 1 BOTTLE (50228-136-10)
50228-136-305022801363030 TABLET in 1 BOTTLE (50228-136-30)
50228-136-905022801369090 TABLET in 1 BOTTLE (50228-136-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bd7fe481-dfe7-4dfd-aa05-6e2318a9234e
  • NADAC price for package 50228013630

    GET /v1/drugs/nadac/50228013630
  • NADAC price for package 50228013690

    GET /v1/drugs/nadac/50228013690

Use it

Look up 50228-136 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-136 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-136. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.